PMA device
Inspire Medical Systems, Model 2580 Patient Programmer
Inspire Medical Systems · Stimulator, Hypoglossal Nerve, Implanted, Apnea (MNQ, Class III) · First FDA decision Dec 18, 2021, newest Dec 18, 2021Sleep apnea
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
8
Naming "Inspire Medical"
MAUDE reports
3
Brand "Inspire Medical", since 2015
PubMed studies
45
Mentioning "Inspire Medical"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Inspire Medical Systems, Model 2580 Patient Programmer
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Inspire Medical Systems, Model 2580 Patient ProgrammerPMA supplement
P130008-S069 · Decided Dec 18, 2021 · 204 days after receipt · Normal 180 Day Track
Device type: Stimulator, hypoglossal nerve, implanted, apnea (MNQ) · Anesthesiology & Respiratory
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep ApneaLocal determinationIn effectL38387Wellpoint FederalUpdated Jul 14, 2026
- Hypoglossal Nerve Stimulation for Obstructive Sleep ApneaLocal determinationIn effectL38276Palmetto GBAUpdated May 8, 2026
- Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep ApneaLocal determinationIn effectL38528WPS Insurance CorporationUpdated Mar 20, 2026
- Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep ApneaLocal determinationIn effectL38307CGS Administrators, LLCUpdated Feb 27, 2026
- Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep ApneaLocal determinationIn effectL38310Noridian Healthcare Solutions, LLCUpdated Oct 16, 2025
- Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep ApneaLocal determinationIn effectL38398First Coast Service Options, Inc.Updated Jan 24, 2020
- Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep ApneaLocal determinationIn effectL38385Novitas Solutions, Inc.Updated Jan 24, 2020
- Transcutaneous Electrical Nerve Stimulators (TENS) - RETIREDNational determinationOn the books280.13Updated Jun 7, 2024
Clinical trials
Device studies on ClinicalTrials.gov that name "Inspire Medical", any status and sponsor, newest update first.
- Use of VR for Diagnostic HysteroscopyRecruiting
St. Justine's HospitalAcademic, hospital or other
NCT07173231 · 45 participants (planned) · Start Jul 8, 2026 · Primary completion May 2027
Device: Immersive Virtual Reality Distraction (IVR); Hypno-Virtual Reality Distraction (HVR) · For: Hysteroscopy; Anxiety; Pain
Sites: Montreal, Canada
- Combination Upper-Airway Electrical and Pharmacological Stimulation for Obstructive Sleep ApneaRecruiting
Brigham and Women's HospitalAcademic, hospital or other
NCT07577661 · 24 participants (planned) · Start Sep 1, 2026 · Primary completion Sep 1, 2028
Device: Unilateral hypoglossal nerve stimulation (HGNS), active comparator condition · For: Obstructive Sleep Apnea; Sleep-disordered Breathing
Sites: Boston, Massachusetts
University Hospital, AntwerpAcademic, hospital or other
NCT05901038 · 138 participants · Start Feb 24, 2023 · Primary completion Sep 1, 2025
Device: Wearing heart rate monitors · For: Exercise; Fitness Tracker; Heart Rate
Sites: Edegem, Belgium
5 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Inspire Medical", and for the whole product code for context.
This brand
3 reports: 0 malfunction, 2 injury, 0 death
Whole product code MNQ
3,753 reports: 165 malfunction, 3,581 injury, 4 death
Newest reports for this brand
MW5157525 · Received Jul 23, 2024 · Event dated May 18, 2024
Device type: Stimulator, Hypoglossal Nerve, Implanted, Apnea (MNQ)
Patient problem as coded: Dysphagia/ Odynophagia; Fatigue; Headache; Failure of Implant; Nausea; Pain; Vertigo; Dizziness; Sleep Dysfunction; Ear Pain
MW5094693 · Received May 26, 2020 · Event dated Jul 18, 2019
Device type: Stimulator, Hypoglossal Nerve, Implanted, Apnea (MNQ)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Pulmonary Edema
3007666314-2016-00010 · Received Oct 26, 2016 · Event dated Aug 3, 2016
Device type: Stimulator, Hypoglossal Nerve, Implanted, Apnea (MNQ)
Device problem as coded: Use of Device Problem
Patient problem as coded: No Code Available
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2515-2026 · Started May 11, 2026 · Posted by FDA Jun 18, 2026
Reason given: Products are labeled with incorrect Use By Date, extending beyond the validated three-year shelf life from date of manufacturer. Material degradation of a product past its Use By Date may result in unplanned or premature revision surgery.
Cause as FDA categorized it: Process control · Device type: Stimulator, Hypoglossal Nerve, Implanted, Apnea (MNQ)
Z-2516-2026 · Started May 11, 2026 · Posted by FDA Jun 18, 2026
Reason given: Products are labeled with incorrect Use By Date, extending beyond the validated three-year shelf life from date of manufacturer. Material degradation of a product past its Use By Date may result in unplanned or premature revision surgery.
Cause as FDA categorized it: Process control · Device type: Stimulator, Hypoglossal Nerve, Implanted, Apnea (MNQ)
Z-2969-2018 · Started Jun 12, 2018
Reason given: Incorrect use-by date on the device registration/patient file labels.
Cause as FDA categorized it: Error in labeling · Device type: Stimulator, Hypoglossal Nerve, Implanted, Apnea (MNQ)
Published research
The most relevant PubMed records for "Inspire Medical"[tiab]. The summary above synthesizes these.
- Upper-airway stimulation for obstructive sleep apnea.
Strollo PJ, Soose RJ, Maurer JT, et al. · N Engl J Med · 2014Multicenter Study, Randomized Controlled Trial
- A Brief History of Hemostasis and Thrombosis at the Mayo Clinic.
Chen D, Pruthi R · Semin Thromb Hemost · 2024Review
- The IMF/NMA medical student mentorship program in health equity in multiple myeloma.
Bhutani M, Testamark S, Morgan RC, et al. · J Natl Med Assoc · 2025
- Intrinsic drive of medical staff: a survey of employee representatives from 22 hospitals in China.
Zhang Y, Yuan Z, Cheng T, et al. · Front Psychol · 2023
- Hypoglossal Nerve Stimulation: Effective Longterm Therapy for Obstructive Sleep Apnea.
Maresch KJ · AANA J · 2018Review
- Evaluation of an Innovative Medical Student Course Integrating Medicine and Public Health.
Jain I, Pillai P, Remington PL · WMJ · 2025
- Perioperative and Perianesthesia Considerations for Hypoglossal Nerve Stimulator Implantation in Obstructive Sleep Apnea Patients.
Maresch KJ · J Perianesth Nurs · 2022Review
- Evaluation of National Anaesthetics Teaching in Undergraduate Medicine (ENATUM).
Kumar PR, Wicks SK, Kumar RV, et al. · Postgrad Med J · 2023
- Characterizing the Landscape of Otolaryngology Trained Hypoglossal Nerve Stimulator Surgeons.
Clementi E, Dowd J, Hakimi A, et al. · Laryngoscope Investig Otolaryngol · 2025
- Nerve Stimulation for the Treatment of Obstructive Sleep Apnea.
Yamauchi M, Satoh M, Kitahara T, et al. · Sleep Biol Rhythms · 2020
- Hypoglossal nerve stimulation for obstructive sleep apnea: A review of the literature.
Wray CM, Thaler ER · World J Otorhinolaryngol Head Neck Surg · 2016Review
- Bilateral vs Unilateral Hypoglossal Nerve Stimulation in Patients With Obstructive Sleep Apnea.
Heiser C, Sommer JU, Hofauer B, et al. · OTO Open · 2022
Other devices of this type
Also filed under product code MNQ.
- Inspire II Upper Airway StimulatorInspire Medical Systems · PMA 2026
- Inspire® Upper Airway StimulationInspire Medical Systems · PMA 2025
- aura6000 systemLivaNova USA, Inc. · PMA 2026
- Genio® System 2.1Nyxoah S.A. · PMA 2025
- Inspire UAS High AHI/High BMIInspire Medical Systems · PMA 2023
- SleepSync ProgrammerInspire Medical Systems · PMA 2023
- Silicone Stimulation Lead, Silicone Sensing LeadInspire Medical Systems · PMA 2022
- Inspire Programmer SystemInspire Medical Systems · PMA 2021
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.